Differential survival of λδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cells

International Journal of Cancer

Volumn 129, Issue 2, 2011, Pages 387-396

  Poggi, Alessandro ^a   Zancolli, Marta ^a   Boero, Silvia ^a   Catellani, Silvia ^b   Musso, Alessandra ^c   Zocchi, Maria Raffaella ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Apoptosis; Bcl 2; Bcl xL; Importins; NF kB

Indexed keywords

ALPHA5 IMPORTIN; KARYOPHERIN ALPHA; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; RETINOIC ACID; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ALPHA BETA T LYMPHOCYTE; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; EFFECTOR CELL; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LEUKEMIA CELL; LYMPHOCYTE FUNCTION; NATURAL KILLER T CELL; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TRANSCRIPTION REGULATION; CELL CULTURE; IMMUNOLOGY; LEUKEMIA; METABOLISM; NATURAL KILLER CELL; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 79961102494     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25682     Document Type: Article

References (48)

1. Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 2007;7: 329-39.
2. Ferrarini M, Ferrero E, Dagna L, Poggi A, Zocchi MR. Human cdT cells: A nonredundant system in the immunesurveillance against cancer. Trends Immunol 2002;23:14-17.
3. Bonneville M, Scotet E. Vgamma9Vdelta2 T cells: Promising new leads for immunotherapy of infections and tumors. Curr Opin Immunol 2006;18: 539-46. (Pubitemid 44311448)
4. Kabelitz D, Wesch D, He W. Perspectives of gammadelta T lymphocytes in tumor immunology. Cancer Res 2007;67:5-8. (Pubitemid 46142752)
5. Kapp M, Rasche L, Einsele H, Grigoleit GU. Cellular therapy to control tumor progression. Curr Opin Hematol 2009;16: 437-43.
6. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000;1:119-26.
7. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC. Regulation of cutaneous malignancy by gamma delta T cells. Science 2001;294: 605-09. (Pubitemid 32999559)
8. Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene 2008;27: 5944-58.
9. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rael and HL60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001;413:165-71. (Pubitemid 32867877)
10. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by cd T cells. Science 1998;279: 1737-40.
11. Bauer S, Groh V, Wu J, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MIC-A. Science 1999;285:727-29.
12. Cosman D, Mullberg J., Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ. ULBPs, novel MHC class-I-related molecules, bind to CMV glicoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001;14:123-133. (Pubitemid 32206515)
13. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nature Rev Immunol 2003;3:781-90. (Pubitemid 37328656)
14. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumorassociated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 1999;96:6879-84. (Pubitemid 29274978)
15. Catellani S, Poggi A, Bruzzone A, Dadati P, Ravetti JL, Gobbi M, Zocchi MR. Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas ex pressing UL-16-binding proteins. Blood 2007;109:2078-85. (Pubitemid 46348208)
16. Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG, Steinle A. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 2003;102: 1389-96. (Pubitemid 36988048)
17. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000;12: 721-27.
18. Poggi A, Venturino C, Catellani S, Clavio M, Miglino M, Gobbi M, Steinle A, Ghia P, Stella S, Caligaris-Cappio F, Zocchi MR. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by transretinoic acid. Cancer Res 2004;64: 9172-9179. (Pubitemid 39665533)
19. Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res 2005;65:6321-29. (Pubitemid 40994418)
20. Rohner A, Langenkamp U, Siegler U, Kalberer CP, Wodnar-Filipovicz A. Differentiation-promoting drugs upregulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. Leuk Res 2007;31: 1393-402. (Pubitemid 47212430)
21. Poggi A, Catellani S, Garuti A, Pierri I, Gobbi M, Zocchi MR. Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. Leukemia 2009; 23:641-48.
22. Gross O, Group C, Steinberg C, Zimmermann S, Strasser D, Hannessclagher N, Reindl W, Johnsson H, Huo H, Littman DR, Peschel C, Yokoyama WM, et al. Multiple ITAM-coupled NKcell receptors engage tha Bcl10/Malt1 complex via Carma1 for NF-kB and MAPK activation to selectively control cytokine production. Blood 2008;112: 2421-28.
23. Ferrarini M, Consogno G, Rovere P, Sciorati C, Dagna L, Resta D, Rugarli C, Manfredi AA. Inhibition of caspases maintains the antineoplastic function of gammadelta T cells repeatedly challenged with lymphoma cells. Cancer Res 2001;61: 3092-95. (Pubitemid 32691959)
24. Spaggiari GM, Contini P, Dondero A, Carosio R, Puppo F, Indiveri F, Zocchi MR, Poggi A. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood 2002; 100:4098-107. (Pubitemid 35396878)
25. Contini P, Zocchi MR, Pierri I, Albarello A, Poggi A. In vivo apoptosis of CD8+ lymphocytes in acute myeloid leukemia patients: Involvement of soluble HLA-I and Fas ligand. Leukemia 2007;21:253-60. (Pubitemid 46158117)
26. Groh V, Wu J, Yee C, Spies T. Tumorderived soluble MIC ligands impair expression of NKG2D and T cell activation. Nature 2002;419:734-38. (Pubitemid 35177960)
27. Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol 2003;171:6891-99. (Pubitemid 37532125)
28. Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, Hayashi N. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 2005;43:1013-20. (Pubitemid 41627987)
29. Poggi A, Contini P, Catellani S, Setti M, Murdaca G, Zocchi MR. Regulation of cdT cell survival by soluble HLA-I. Involvement of CD8 and activating killer Ig-like receptors. Eur J Immunol 2005;35:2670-78. (Pubitemid 41404050)
30. Waldhauer I, Steinle A. Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Cancer Res 2006;66:2520-26.
31. Poggi A, Catellani S, Bruzzone A, Caligaris-Cappio F, Gobbi M, Zocchi MR. Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division. Leukemia 2008;22:980-88. (Pubitemid 351689880)
32. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cavé H, Pane F, Aerts JL, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-a Europe Against Cancer program. Leukemia 2003;17:2318-57. (Pubitemid 38072573)
33. Fleige S, Walf W, Huch S, Prgomet C, Sehm J, Pfaffl MW. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 2006;28: 1601-13. (Pubitemid 44306128)
34. Poggi A, Massaro AM, Negrini S, Contini P, Zocchi MR. Tumor-induced apoptosis of human IL-2-activated NK cells: Role of natural cytotoxicity receptors. J Immunol 2005;174:2653-60. (Pubitemid 40279679)
35. Fuller CL, Ravichandran KS, Braciale VL. Phosphatidylinositol 3-kinase-dependent and -independent cytolytic effector functions. J Immunol 1999;162:6337-40. (Pubitemid 29309352)
36. Jiang K, Zhong B, Gilvary DL, Corliss BC, Hong-Geller E, Wei S, Djeu JY. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat Immunol 2000;1:419-25.
37. Ferrero E, Belloni D, Contini P, Foglieni C, Ferrero ME, Fabbri M, Poggi A, Zocchi MR. Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+CD14+ circulating precursors: Evidence for PECAM-1 involvement through Akt/PKB activation. Blood 2003;101:186-93. (Pubitemid 36025907)
38. Turco MC, Romano MF, Petrella A, Bisogni R, Tassone P, Venuta S. NFkappaB/ Rel-mediated regulation of apoptosis in hematological malignancies and normal hematopoietic progenitors. Leukemia 2004;18:11-17. (Pubitemid 38159433)
39. Jiang HY, Petrovas C, Sonenshein GE. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: Differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members. J Virol 2002; 76:5737-47. (Pubitemid 34517924)
40. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ. BCL-2, BCL-XL sequester BH3 domain-only molecules preventing Bax-and Bakmediated mitochondrial apoptosis. Mol Cell 2001;8:705-11. (Pubitemid 32946946)
41. Grimm T, Schneider S, Naschberger E, Huber J, Guenzi E, Kieser A, Reitmeir P, Schulz TF, Morris CA, Stürzl M. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood 2005;105:3263-69.
42. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial disfunction and apoptosis. EMBO J 1998;17:3878-85. (Pubitemid 28333974)
43. Torgerson TR, Colosia AD, Donahue JP, Lin YZ, Hawiger J. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50. J Immunol 1998;161:6084-92. (Pubitemid 28535979)
44. Fagerlund R, Melen K, Cao X, Julkunen I. NF-kB p52, RelB and cRel are transported into the nucleus via a subset of importin a molecules. Cell Signal 2008;20:1442-51.
45. Strid J, Roberts SJ, Filler RB, Lewis JM, Kwong BY, Schpero W, Kaplan DH, Hayday AC, Girardi M. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogensis. Nat Immunol 2008;9:146-54.
46. Hayday AC. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 2009;31:184-96.
47. Maccalli C, Pende D, Castelli C, Mingari MC, Robbins PF, Parmiani G. NKG2D engagement of colorectal cancer-specific T cells strengthen TCR-mediated antigen stimulation and elicit TCR-independent anti-tunor activity. Eur J Immunol 2003;33: 2033-2043. (Pubitemid 37120876)
48. Weng N-p, Akbar AN, Goronzy J. CD28-T cells: Their role in the age-associated decline of immune function. Trend Immunol 2009;30:306-312.